Learn more about COVID-19 in Saskatchewan. Daily case numbers and information for businesses and workers.

The Re-Open Saskatchewan plan was released on April 23rd.

Google Translate Disclaimer

A number of pages on the Government of Saskatchewan's website have been professionally translated in French. These translations are identified by a yellow text box that resembles the link below and can be found in the right hand rail of the page. The home page for French-language content on this site can be found at:

Renseignements en Français

Where an official translation is not available, Google™ Translate can be used. Google™ Translate is a free online language translation service that can translate text and web pages into different languages. Translations are made available to increase access to Government of Saskatchewan content for populations whose first language is not English.

The results of software-based translation do not approach the fluency of a native speaker or possess the skill of a professional translator. The translation should not be considered exact, and may include incorrect or offensive language Government of Saskatchewan does not warrant the accuracy, reliability or timeliness of any information translated by this system. Some files or items cannot be translated, including graphs, photos, and other file formats such as portable document formats (PDFs).

Any person or entities that rely on information obtained from the system does so at his or her own risk. Government of Saskatchewan is not responsible for any damage or issues that may possibly result from using translated website content. If you have any questions about Google™ Translate, please visit: Google™ Translate FAQs.

Recommendations for Nebulizer to Metered Dose Inhaler Interchange in SHA Acute Care Facilities

Key Messages:

  1. Meter Dose Inhalers (MDIs) are preferred over nebulization
  2. MDI stock is limited – assessment if a MDI is required for non-Influenza Like Illness (ILI) patients

To reduce the risk of transmission via droplets and aerosols, the pharmacy department in SHA acute care facilities will substitute all newly ordered nebulized medications that have metered dose inhaler (MDI) equivalents.  

  • The use of MDIs is shown to be as effective as nebulization. In addition, MDIs reduce the generation of aerosol particles, expedite treatment and require less staffing resources, but most importantly ensure safety. The use of MDIs instead of nebulizers has been written into the Work Standard when patients with ILI symptoms present to our acute care emergency departments.

  • Nebulized medications will be restricted to the following:
  1. Severe life-threatening respiratory disease which may include end-stage COPD and cystic fibrosis
  2. Patients unable and uncooperative to use MDI.  Isolation measures are required

Dosing conversions are as per table 1. This will be implemented as an automatic therapeutic substation effective immediately, during and following resolution of the COVID-19 pandemic.  

In the event that a nebulizer is required, the prescriber must specifically specify in the written order that a nebulized solution is required (eg. no sub).

Table 1: Nebulizer to Metered Dose Inhaler (MDI) Conversion

 Drug Name
(Nebules)
Nebulized Dose  MDI Drug Equivalent  MDI Equivalent Dose 
 Salbutamol 1 mg/mL (2.5 ml)
2.5 mg = 1 nebule  
2.5 mg Salbutamol 100 mcg/puff  2 puffs
Ipratropium 0.25 mg/mL 
0.5 mg (500 mcg) = 2 mL = 1 nebule
1 neb Ipratropium 20 mcg/puff  2 puffs
Combivent® 
(ipratropium/salbutamol 0.5 mg /2.5 mg) = 1 nebule
1 neb Combivent Respimat® 
(ipratropium/salbutamol 20 mcg/100 mcg)/puff 
1 puff
Budesonide 0.5 mg/mL (2 mL) 1 mg = 2 mL = 1 nebule 1 neb - Fluticasone propionate 125 mcg/puff  2 puffs

Metered dose inhalers are for individual patients and must never be shared. They are to be labelled patient-specific and stored in a patient-specific location. Once the inhaler order has been discontinued or the patient is discharged, the inhaler must be properly disposed of.  Inhalers may be sent home with the patient if they are ordered on discharge.

Newhouse, Michael T. “RE: Transmission of Corona Virus by Nebulizer- A Serious, Underappreciated Risk” CMAJ, 4 Mar. 2020,

RE: Transmission of Corona Virus by Nebulizer- a serious, underappreciated risk!

Practices to minimize aerosolizing procedures for patients on droplet precautions. 

Lexi-Drugs. Lexicomp. Wolters Kluwer Health, Inc. Riverwoods, IL. Available at: http://online.lexi.com.

S.A. Alhaider, H.A. Alshehri, K. Al-Eid. Replacing nebulizers by MDI-spacers for bronchodilator and inhaled corticosteroid administration: Impact on the utilization of hospital resources. International Journal of Pediatrics and Adolescent Medicine,Volume 1, Issue 1, 2014,Pages 26-30

We need your feedback to improve saskatchewan.ca. Help us improve